Built by
scientific experts
A lean team empowered by a global network to drive results.
The team driving Klyv Therapeutics forward
Maria Vistnes, Md, PhD
Chief Executive Officer
Hanne Bonge-Hansen, PhD, EPA
Chief Operating Officer
Athanasios Didangelos, PhD
Consultant, biology
Charles-Henry Fabritius, PhD
Consultant, medicinal chemistry
Ellen van der Aar, PhD
Consultant, ADME / DMPK / early development
Andy Morley, PhD
Consultant, medicinal chemistry
Collaborators
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
Support from
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.
No approved anti-fibrotic therapy exists for HFpEF in a market projected at $2 billion USD by 2025.